European Commission Report on Nanomaterials – 2021
The European Commission is required to submit to the European Parliament and the Council an annual status report on the use of nanomaterials in cosmetic products and to review the provisions concerning nanomaterials in the European Regulation (EC) No 1223/2009 on cosmetic products. In July 2021, the Commission has issued its latest annual report on this subject.


Nanomaterials consist of very small particles that cannot be observed by the human eye and can be present in nature or may be manufactured and added to consumer products in order to provide specific properties. The very small size of these materials provides special physical and chemical properties (e.g., color change when compared to non-nano form), but it can also influence the hazard properties of a specific nanomaterial. This means that some nanomaterials may have potential intrinsic hazards that are not observed in their non-nano form.

According to the European Regulation (EC) No 1223/2009 on cosmetic products (‘Cosmetics Regulation), nanomaterial means “an insoluble or biopersistent and intentionally manufactured material whit one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm”. However, this definition may suffer adjustments in time by the Commission, according to the constant technical and scientific developments in the field of nanotechnologies.

Cosmetic products containing nanomaterials must follow specific regulatory provisions. For every cosmetic product that contains nanomaterials, a high level of protections of human health shall be ensure. So, when notifying a cosmetic product, the presence substances in the nano form needs to be identified. The cosmetics containing nanomaterials must be notified by the Responsible Person (by electronic means) six months before being placed on the market (except for colorants, UV-filters and preservatives included in the Annexes of the Regulation). If there are concerns regarding the safety of a nanomaterial, the Commission shall, without delay, request the Scientific Committee on Consumer Safety (SCCS) to give its opinion on the safety of this nanomaterial for use in relevant categories of cosmetic products and on the reasonably foreseeable exposure. The SCCS shall deliver its opinion within 6 months of the Commission’s request (see our previous post on nanomaterials).

Pursuant to Article 16 (10) and (11) of the Cosmetics Regulation, the Commission is required to submit to the European Parliament and the Council an annual status report on the use of nanomaterials in cosmetic products and to review the provisions concerning nanomaterials in cosmetic products regulation.


The European Commission has published in July 2021 the report on the use of nanomaterials in cosmetics and on the review of the Regulation (EC) No 1223/2009 on cosmetic products in regard to nanomaterials.

According to data extracted from the Cosmetic Product Notification Portal (CPNP), every day about 800 new cosmetic products are notified and placed on the EU market. Moreover, about 10 new cosmetic products containing nanomaterials are placed in the EU market every day.

The report states that “the use of nanomaterials in cosmetic products is limited (1.5% of all products) and seems to be rather stable over the past five years (2016-2020)”.

In 2020, 3,444 notifications were submitted under Article 13 of the Cosmetics Regulation for nanomaterials listed in the Annexes IV, V and VI; for all other nanomaterials only 137 notifications were made in accordance with Article 16 of the Cosmetics Regulation. About 96% of notifications made last year correspond to cosmetic products containing nanomaterial ingredients with a colourant or UV filter function. The 4 most used chemical substances (over 70% of all CPNP nanomaterial notifications) are:

  • Titanium Dioxide
  • Silica Dimethyl Silylate, Silane, dichlorodimethyl-, reaction products with silica
  • Carbon Black nano (CI 77266)
  • Silica

Sun protection, nail varnish/nail make up, oxidative hair care, foundation, lip care products and lipstick are the most common product categories associated with the notified cosmetic products containing nanomaterials.

There are significant differences on the percentage of cosmetic products containing nanomaterials notified in the 5 EU countries (France, Germany, Italy, Spain and Poland) with highest number of total CPNP notifications (0.8 – 5%) and in the country’s contribution to the total EU notifications of nanomaterials (from 6.5% (Poland) to 43.7% (France)). The Commission considers that it is plausible to assume that the divergence found may result from differences in the implementation by national authorities and/or economic operators of the nanomaterials definition and, consequently, of the relevant notification obligations.

In the last 10 years, the SCCS has issued more than 20 opinions and guidance documents on nanomaterials used in cosmetic products. The majority of the recent SCCS opinions (2015-2020) on CPNP-notified nanomaterials were inconclusive, due to the lack of or insufficient data. The Commission deems that there is a need for responsible persons to provide information as accurate as possible when notifying nanomaterials present in cosmetics.

According to the Section 2 of the Commission’s Report (Review of the Provisions Concerning Nanomaterials), the cosmetics definition of nanomaterials might be adapted to the upcoming revised general definition to be presented in 2021. The main reason for this revision is the highlighted differences found between the definition of nanomaterials in the Cosmetics Regulation and the 2011 Commission Recommendation on the definition of nanomaterial.

The Notification Process via CPNP will also be revised, putting specific attention in the duration and effect of the expiry date of the deadline as laid out in the Cosmetics Regulation.

Considering the importance to most EU citizens of being well informed on the presence of nanomaterials, digital labelling could be considered to complement and further improve the labelling of nanomaterials in cosmetic products.


  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Scientific Committee on Consumer Safety (SCCS). Scientific Advice on the safety of nanomaterials in cosmetics. (SCCS/1618/20). Corrigendum of 8 March 2021.
  3. Report from the Commission to the European Parliament and the Council on the use of nanomaterials in cosmetics and on the review of Regulation (EC) No 1223/2009 on cosmetic products as regard nanomaterials. Brussels, 22.7.2021.


medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
medical devices

Amendments to the Transitional Provisions of the European Union MDR and IVDR

The proposed amendments aim to maintain patients’ access to a wide range of medical devices while ensuring the transition to the new framework. The ammendments proposal aims to extend the current transition period (Article 120 of the MDR), and it also deletes the ‘sell-off’ deadlines of both MDR and IVDR. The extension is staggered depending on the risk class of the device – until December 2027 for high-risk devices and December 2028 for medium and lower-risk devices.

Read More »
medical devices

EU MDR – Proposal for Extension of Transition Period

The transition to MDR has been slower than anticipated by the European Commission. Insufficient capacity of notified bodies and the low level of preparedness of manufacturers led to a proposal for extension of current MDR transition period with deadlines depending on the risk class of the devices.

Read More »
medical devices

MDCG 2022-18 – EU MDR Article 97

EU MDR Article 97 may be a temporary solution to avoid disruption of supply of Medical Devices on the EU Market. The MDCG 2022-18 presents a uniform approach for application of MDR Article 97 on non-compliant legacy devices under the conditions set by the competent authorities, while limiting the impact on the supply of safe and effective devices.

Read More »
cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »